INCYTE CORP (INCY:NASDAQ)
$113.31 -2.4 (-2.0742%)
Analysed INCYTE CORP (INCY:NASDAQ) News Sources
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
24-10-2026
yahoo.com
Incyte (INCY) Heads To ESMO With New Oncology Data, Is The Stock Still Undervalued?
24-10-2026
yahoo.com
Incyte (INCY) Starts KRAS G12D Colorectal Cancer Trial Collaboration
24-10-2026
yahoo.com
Does Genmab Trial Deal Change The Bull Case For Incyte (INCY)?
24-10-2026
yahoo.com
Is Incyte (INCY) Cheap After A 120% Three Year Run?
24-10-2026
yahoo.com
Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech Watchlist
26-10-2026
stocktwits.com
Can Incyte Stock Hit $170?
26-10-2026
trefis.com
Incyte Highlights New Data Advancing its Gastrointestinal Cancer Portfolio at ESMO 2026
26-10-2026
yahoo.com
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
26-10-2026
yahoo.com
Genmab's Encouraging Oncology Data Boosts Investor Optimism
26-10-2026
yahoo.com
What is the current price of INCYTE CORP (INCY:NASDAQ)?
The current price of INCYTE CORP (INCY:NASDAQ) is $113.31.
INCYTE CORP (INCY:NASDAQ) absolute price change since previous trading day?
The absolute price change of INCYTE CORP (INCY:NASDAQ) since the previous trading day is $-2.4.
INCYTE CORP (INCY:NASDAQ) percentage price change since previous trading day?
The percentage price change of INCYTE CORP (INCY:NASDAQ) since the previous trading day is -2.0742%.
What is the most recent average sentiment score for INCYTE CORP (INCY:NASDAQ)?
The most recent average sentiment score for INCYTE CORP (INCY:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for INCYTE CORP (INCY:NASDAQ)?
The most recent sentiment for INCYTE CORP (INCY:NASDAQ) is .
SEC-8K** Filing Available For INCYTE CORP (INCY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.